Back to Pathology Classification
MP-001Chronic

Market Denial

Also known as: Disruption Blindness, Market Reality Rejection, Strategic Myopia

Market PathologyTechnology-induced

Key researchers: Christensen

Definition

A market pathology characterized by systematic failure to recognize or respond to fundamental market shifts. The organization maintains strategic commitments to markets, technologies, or business models that are being disrupted or rendered obsolete.

Diagnostic Criteria

  1. Strategic plans assume market continuity despite contrary evidence
  2. Dismissal of disruptive competitors as 'niche' or 'not real competition'
  3. Investment patterns favoring legacy business over emerging opportunities
  4. Leadership communications denying or minimizing market shifts
  5. Customer feedback indicating changing needs systematically ignored

Symptoms

  • Strategic planning disconnected from market reality
  • Competitive response delays (years behind)
  • Customer defection to alternatives
  • Margin compression denial ('temporary' price pressure)
  • Innovation theater (activity without adaptation)

Disease Stages

1

Stage 1: Early signals (dismissed as noise)

2

Stage 2: Mounting evidence (rationalized away)

3

Stage 3: Crisis (denial finally breaks)

4

Stage 4: Too-late response or organizational failure

Typical Course

Chronic pattern, often spanning years or even a decade. Punctuated by periodic 'wake-up calls' that are insufficiently processed. Terminal when market shifts become irreversible and organization lacks resources to transform.

Etiology

Cognitive biases (confirmation bias, sunk cost fallacy), organizational identity attachment to legacy business, incentive structures favoring status quo defense, and misplaced optimism about core business recovery combine to create systematic blindness.

Risk Factors

  • Dominant market position (success trap)
  • Significant sunk costs in legacy business
  • Strong organizational identity tied to legacy
  • Executive compensation tied to legacy business metrics
  • Key customer relationships in declining segments

Differential Diagnosis

Conditions that may present similarly or co-occur:

Structural Inertia (often co-occurs - denial + inability to change)Leadership Vacuum (can enable denial through lack of strategic direction)Founder's Syndrome (if founder attached to original vision)

Prognosis

Poor without leadership change or external shock forcing recognition. Disruption windows are finite. Early recognition and pivot essential. Many incumbents fail to navigate major market transitions.

References

Defining Source

Christensen, C.M. (1997). The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail. Harvard Business School Press

Abstract

This groundbreaking book explains why great companies fail when faced with disruptive innovation. Christensen shows how organizational processes and values that make companies successful also make them systematically blind to threats from below-market innovations that improve over time.

Additional Sources

  1. Christensen, Clayton M. (2013) - The Innovator's Dilemma: When New Technologies Cause Great Firms to Fail

Known Cases

  • Kodak (digital photography)
  • Blockbuster (streaming)
  • Nokia (smartphones)
  • Traditional taxi companies (ridesharing)

Classification

Code
MP-001
Localization
Market Pathology
Primary Etiology
Technology-induced
Typical Course
Chronic
Functional Impairment
Perception

Contribute

See an error or have additional information? Help improve this entry.